We are live on ! Find out more
VC

Vivo Capital Portfolio holdings

AUM $1.2B
1-Year Est. Return 911.44%
This Fund
S&P 500
This Quarter Est. Return
+47.91%
1 Year Est. Return
+911.44%
3 Year Est. Return
+7,373.93%
5 Year Est. Return
+10,475.15%
10 Year Est. Return
+136,503.27%
AUM
$913M
AUM Growth
-$536M
Cap. Flow
+$46.2M
Cap. Flow %
5.06%
Top 10 Hldgs %
62.91%
Holding
56
New
8
Increased
8
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
+$25.3M
2
SLNO
Soleno Therapeutics
SLNO
+$19.4M
3
CMPS
Compass Pathways
CMPS
+$14.2M
4
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$13.3M
5
APGE icon
Apogee Therapeutics
APGE
+$8.81M

Top Sells

Rank Stock Value
1
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$39.4M
2
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$35.9M
3
ASLN
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
+$5.21M
4
IMUX icon
Immunic
IMUX
+$1.59M
5
CLNN icon
Clene
CLNN
+$1.3M

Sector Composition

Rank Sector Weight
1 Healthcare 99.8%
2 Consumer Staples 0.15%
3 Materials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRS
51
DELISTED
Amyris Inc.
AMRS
$465K 0.05%
7,750,828
– –
QTTB icon
52
Q32 Bio
QTTB
$482M
$433K 0.05%
20,559
– –
DTIL icon
53
Precision BioSciences
DTIL
$191M
$47.9K 0.01%
4,675
– –
IMUX icon
54
Immunic
IMUX
$198M
– –
-63,218
Closed -$1.59M
KDNY
55
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-934,879
Closed -$35.9M
VECT
56
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
– –
-2,333,300
Closed -$39.4M
1 2
3

Similar funds

FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
MB
MidFirst Bank Oklahoma City, Oklahoma $1.21B AUM
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

Vivo Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Vivo Capital held 56 positions worth $913M, down 37% from $1.45B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Vivo Capital deployed $46.2M of net new capital in Q3 2023, opening 8 new positions and adding to 8 existing holdings. Its largest new stake was Soleno Therapeutics: 3,203,093 shares worth $94.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier, followed by Consumer Staples and Materials.

On the sell side, the largest reduction was ASLAN Pharmaceuticals Limited American Depositary Shares, an estimated $5.21M trimmed.

  • Vivo Capital's largest Q3 2023 buy was Soleno Therapeutics: 3,203,093 shares worth $94.5M.
  • Vivo Capital added most to Gracell Biotechnologies Inc. American Depositary Shares in Q3 2023, an estimated $25.3M increase.
  • Vivo Capital's biggest Q3 2023 reduction was ASLAN Pharmaceuticals Limited American Depositary Shares, cutting an estimated $5.21M.
  • Vivo Capital fully exited VectivBio Holding AG Ordinary Shares in Q3 2023, selling an estimated $39.4M.
  • Vivo Capital's ten largest holdings make up 63% of its $913M portfolio in Q3 2023.
  • Vivo Capital opened 8 new positions and closed 3 in Q3 2023.
  • Vivo Capital's portfolio value fell 37% quarter-over-quarter to $913M.

Based on Vivo Capital's 13F filing for Q3 2023, filed 8 Nov 2023.